- Report
- April 2025
- 200 Pages
Global
From €3960EUR$4,490USD£3,428GBP
- Report
- August 2025
- 195 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Report
- August 2025
- 180 Pages
Global
From €3969EUR$4,500USD£3,436GBP
- Report
- September 2025
- 197 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Report
- September 2025
- 273 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Report
- September 2025
- 604 Pages
Global
From €5159EUR$5,850USD£4,466GBP
- Report
- January 2025
- 178 Pages
Global
From €4405EUR$4,995USD£3,814GBP
- Report
- April 2024
- 330 Pages
Global
From €4366EUR$4,950USD£3,779GBP
- Report
- October 2023
- 103 Pages
Global
From €3500EUR$4,251USD£3,136GBP
- Report
- October 2024
- 93 Pages
Global
From €3500EUR$4,251USD£3,136GBP
- Report
- March 2025
- 360 Pages
Global
From €2342EUR$2,655USD£2,027GBP
Therapeutic Plasma Exchange (TPE) is a process used in blood banking to treat a variety of medical conditions. It involves the removal of plasma from a patient's blood and replacing it with donor plasma or a plasma substitute. The process is used to treat conditions such as autoimmune diseases, thrombotic thrombocytopenic purpura, and hemolytic anemia. It is also used to remove antibodies and other substances from the blood that can cause adverse reactions.
TPE is a specialized procedure that requires specialized equipment and trained personnel. It is typically performed in a hospital or clinic setting. The process is usually done in a series of treatments, with the number of treatments depending on the condition being treated.
The TPE market is a growing segment of the blood banking industry. It is a highly specialized field that requires specialized equipment and personnel. Companies in the market include Haemonetics Corporation, Fresenius Kabi, Terumo BCT, and Asahi Kasei Medical. Show Less Read more